Based on author's thesis (doctoral - University College, Cork. Law Department, 2015) issued under title: Preserving patent policy space and securing access to medicines in developing countries : the role of states and pharmaceutical corporations. Includes bibliographical references and index.
Contents:
Introduction -- Patent policy, access to medicines, and the regulatory theory of patent rights -- The interface between patent rights and the right to health under international human rights law -- Incorporating a model of human rights into the adjudication of pharmaceutical patent cases (part one) : Kenya as a case study -- Incorporating a model of human rights into the adjudication of pharmaceutical patent cases (part two) : South Africa as a case study -- Incorporating a model of human rights into the adjudication of pharmaceutical patent cases (part three) : India as a case study -- Conclusion.
Summary:
"Payment for pharmaceutical products has long been identified as one of the potential causes of poverty in developing countries. Moreover, there is a cyclical relationship between poverty and poor health. In relation to developing countries, the health challenges confronting them is exacerbated by the high incidence of both communicable and non-communicable diseases in these countries ... These figures indicate that in the years to come, poor patients in these and other developing countries will continue to require access to medicines at affordable prices in order to sustain a healthy and productive life-style."-- Provided by publisher.
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.